# The Paradigm II Trial: PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemic Attack, Migraine or Decompression Illness

> **NCT00196040** · NA · COMPLETED · sponsor: **Cierra** · enrollment: 60 (—)

## Conditions studied

- Foramen Ovale, Patent

## Interventions

- **DEVICE:** PFX Closure System

## Key facts

- **NCT ID:** NCT00196040
- **Lead sponsor:** Cierra
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** —
- **Final completion:** 2007-11
- **Target enrollment:** 60 (—)
- **Last updated:** 2007-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00196040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00196040, "The Paradigm II Trial: PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemic Attack, Migraine or Decompression Illness". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00196040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*